Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.37 |
| ▸ | FASN | P49327 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.35 |
| ▸ | VCP | P55072 | 1/20 | 0.34 |
| ▸ | CISD2 | Q8N5K1 | 2/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
| ▸ | NEU3 | Q9UQ49 | 1/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.33 |
| ▸ | KLK1 | P06870 | 1/20 | 0.33 |
| ▸ | IKBKB | O14920 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24287368 | 0.83 | KDM4E (0.33) | KDM4EGPR35ALDH1A1 | |
| SCHEMBL28057063 | 0.83 | HSP90AB1 (0.43) | KDM4EEGLN1FASNMAPK8CISD2 | |
| SCHEMBL31431699 | 0.83 | ALOX5 (0.43) | KDM4EEGLN1ALDH1A1 | |
| SCHEMBL28056987 | 0.83 | FLT1 (0.40) | POLBALOX5APGPR35 | |
| SCHEMBL29669953 | 0.81 | KDM4E (0.59) | KDM4EGPR35 | |
| SCHEMBL21990971 | 0.81 | KDM4E (0.42) | KDM4EVCPLRRK2GPR35ALDH1A1 | |
| SCHEMBL19125812 | 0.81 | KDM4E (0.42) | KDM4EFASNALDH1A1IKBKB | |
| SCHEMBL31432230 | 0.81 | KDM4E (0.42) | KDM4EFASNALDH1A1IKBKB | |
| SCHEMBL951068 | 0.81 | KDM4E (0.59) | KDM4EGPR35 | |
| SCHEMBL3140934 | 0.81 | EGLN1 (0.35) | EGLN1FASNPOLBALOX5APLRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676908-A1 | PHOTOCHEMICAL SYSTEMS AND METHODS FOR PREPARING CYANOBENZAMIDES | FMC Corporation (US) | 2026-01-14 | — | — | EP | claimed |
| CN-119431187-A | Preparation method of key intermediate of chlorantraniliprole | 山东垄喜植物保护有限公司 | 2025-02-14 | — | — | CN | claimed |
| WO-2024186513-A1 | PHOTOCHEMICAL SYSTEMS AND METHODS FOR PREPARING CYANOBENZAMIDES | FMC CORPORATION (US) | 2024-09-12 | — | — | WO | claimed |
| CN-117186060-A | Production method of o-carboxamido benzamide compound | 山东友道化学有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-117186059-A | Production method of bisamide compound | 山东友道化学有限公司 | 2023-12-08 | — | — | CN | claimed |
| US-20230312505-A1 | SOLID STATE FORMS OF CYANTRANILIPROLE | ADAMA MAKHTESHIM LTD. (IL) | 2023-10-05 | — | — | US | claimed |
| CN-116490492-A | Solid state form of cyantraniliprole | 安道麦马克西姆有限公司 | 2023-07-25 | — | — | CN | claimed |
| EP-4165031-A1 | SOLID STATE FORMS OF CYANTRANILIPROLE | Adama Makhteshim Ltd. (IL) | 2023-04-19 | — | — | EP | claimed |
| EP-2729444-B1 | METHOD FOR MANUFACTURING 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | BAYER IP GMBH (DE) | 2017-08-23 | — | — | EP | claimed |
| EP-2254858-B1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | DU PONT (US) | 2016-09-28 | — | — | EP | claimed |
| WO-2013007603-A1 | METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-01-17 | — | — | WO | claimed |
| US-8247570-B2 | Process for preparing 2-amino-5-cyanobenzoic acid derivatives | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-08-21 | — | — | US | claimed |
| US-8242279-B2 | Process for preparing 2-amino-5-cyanobenzoic acid derivatives | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-08-14 | — | — | US | claimed |
| US-20120130080-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | FMC CORPORATION | 2012-05-24 | — | — | US | claimed |
| US-20110003998-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | E. I. DU PONT NEMOURS AND COMPANY | 2011-01-06 | — | — | US | claimed |
| US-20100280251-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-04 | — | — | US | claimed |
| EP-2231592-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | E. I. du Pont de Nemours and Company (US) | 2010-09-29 | — | — | EP | claimed |
| EP-2094644-A2 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | E. I. Du Pont de Nemours and Company (US) | 2009-09-02 | — | — | EP | claimed |
| WO-2009085816-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-07-09 | — | — | WO | claimed |
| WO-2008082502-A2 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-07-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312505-A1 | SOLID STATE FORMS OF CYANTRANILIPROLE | SHBG, LHCGR, PRLHR | KDM4E 710/4885EGLN1 2891/4885FASN 3899/4885 |
| US-20110003998-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | C5, CBR3, C9 | KDM4E 1327/4885EGLN1 3403/4885FASN 3587/4885 |
| US-20100280251-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | CBR3, CBR1, CYB5R3 | KDM4E 1784/4885EGLN1 3532/4885FASN 3112/4885 |
| US-20120130080-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | C9, CLIC4, C5 | KDM4E 1061/4885EGLN1 3381/4885FASN 3628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.